Connor, Clark & Lunn Investment Management (CC&L)’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-106,371	Closed	-$330K	–	1305
2021 Q4	$330K	Buy	106,371 +40,765	+62%	+$137K	﹤0.01%	873
2021 Q3	$237K	Buy	+65,606	New	+$247K	﹤0.01%	923

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BDSI Position: Q1 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 106,371 shares — an estimated $330K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BDSI in Q3 2021 and held it in 2 quarters. The position peaked at $330K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 106,371 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $330K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BioDelivery Sciences International, Inc. in Q3 2021 and held it in 2 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s BioDelivery Sciences International, Inc. position peaked at $330K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.